Syros Pharmaceuticals Inc...

NASDAQ: SYRS · Real-Time Price · USD
0.03
0.00 (19.52%)
At close: Jun 09, 2025, 3:26 PM

Syros Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-164.57M -94.65M -86.56M
Depreciation & Amortization
2.25M 2.97M 3.02M
Stock-Based Compensation
10.43M 11.41M 10.35M
Other Working Capital
-1.77M -8.28M -12.64M
Other Non-Cash Items
37.13M -37.27M 706K
Deferred Income Tax
n/a n/a -16.46M
Change in Working Capital
5.05M -5.52M -10.6M
Operating Cash Flow
-109.71M -123.06M -99.54M
Capital Expenditures
-272K -1.24M -1.25M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-50.97M n/a -51.41M
Sales Maturities Of Investments
87.02M 68.43M n/a
Other Investing Acitivies
1.56M 68.43M -51.41M
Investing Cash Flow
37.34M 67.19M -52.65M
Debt Repayment
-65K -291K -265K
Common Stock Repurchased
n/a -81K n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
257K 11.66M 439K
Financial Cash Flow
43.46M 131.04M 70.51M
Net Cash Flow
-28.91M 75.17M -81.68M
Free Cash Flow
-109.98M -124.31M -100.78M